References 1 FDA Wegovy (semaglutide) Prescribing InformationFDA-approved labeling for the standalone semaglutide molecule (GLP-1 receptor agonist) for chronic weight management
Functional medicine practitioners are recognizing peptide therapy as a supportive treatment for Lyme disease
A second trial in healthier, community-dwelling older adults showed less dramatic effects, suggesting the intervention may provide more benefit to those who already show measurable deficiency and metabolic stress
Association of coronary calcium score with endothelial dysfunction and arterial stiffness
Untreated cells in 2% or 10% FBS DMEM for 3 days were used as negative controls
Plasma glutathione levels were measured after oral administration at 0, 15 min, 30 min, 1 h, 2 h, and 4 h in each group of six mice